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ABSTRACT
Abstract of the thesis entitled "EFFECT OF VITAMIN D ON RIBONUCLEIC
ACID SYNTHESIS IN BONE" submitted by Sue Ann Shelley in partial fulfillment of the requirements for the degree of Master of Science, June, 1971.
The effect of vitamin D on the incorporation of 3H-uridine into
RNA of rat bone cells was studied using an in vitro system.

Rachitic

rats were treated with 5,000 I.U. of vitamin n3 or with the vehicle
only.

In some experiments each rat received 100 µg of actinomycin D

before treatment with vitamin D or vehicle.

Five hours after the

administration of the vitamin or vehicle the rats were sacrificed and

were dissected out, washed and incubated in medium containing 1 µCi/ml
of 3H-uridine for 4 hours.

After incubation the bone fragments were

washed repeatedly and the bone cells isolated.
In some experiments RNA was extracted from the bone cells with
phenol-sodium dodecyl sulfate and the specific activity of the RNA
determined.

In other experiments the RNA was separated into two.
0

fractions by sequential treatment with phenol-SDS at 45°c and 65 C.
The specific activities of both fractions of RNA were then determined •
. Comparison of the specj:fic activities of the RNAs from vitamin D3
treated and from control rats was used as the basis to determine the
effect of vitamin.D , and vitamin n3 following actinomycin D treatment,
3
on the incorpor~tion of 3n-uridine into RNA.s of rat bone cells.

Treatment with vitamin D3 increased the incorporation of 3H-uridine
into the cytoplasmic RNA of rachitic bone.cells in this in vitro system.
Prior treatment of the animals with actinomycin D largely inhibited this
increased RNA synthesis, but the specific activity of the RNA from
vitamin D treated animals was still greater than that of the controls.
Vitamin D treatment was found to stimulate the incorporation of
3

H-uridine into both RNA which could be extracted at 45°c, which is

believed to be a mixture of cytoplasmic and nucleolar RNAs, and RNA
extracted at 65°c.

The RNA extractable at 65°c is thought to be nucleo-

plasmic RNA with a base ratio similar to that of DNA, and is possibly
a precursor to messenger RNA.

In other tissues synthesis of the 4s 0 c

RNA. has been shown to be inhibited by actinomycin D while the synthesis

was found that actinomycin D did not inhibit the vitamin D stimulated
increase in incorporation of 3H-uridine into either of these fractions
of bone cell RNA.
Vitamin D appears to increase the synthesis of all types of bone
cell RNA.

The vitamin D stimulated synthesis of cytoplasmic RNA could

be largely blocked by pretreatment with actinomycin D, but the vitamin D
stimulated synthesis of nucleolar and nucleoplasmic RNA was unaffected
by actinomycin D treatment.

It appears from these experiments that one

effect of vitamin D is the stimulation of RNA synthesis in bone cells,
/

but the importance of this increased RNA synthesis in the mode of action
of the vitamin is not yet clear.
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CHAPTER I
INTRODUCTION
Vitamin D plays an essential role in the absorption of calcium from
the small intestine and in the mobilization of mineral from bone •. By
these actions it functions to elevate calcium and phosphate levels in the
serum, which are necessary for normal bone mineralization.

The primary

end effect of vitamin D is, therefore, calcification of bone, although a
direct effect of the vitamin on the calcification process has not yet
been demonstrated.

A deficiency of vitamin D then results in defective

calcification of bone.

In young animals, the deficiency disease is

rickets, and in adults, this failure of calcification gives rise to
osteoid seams which are characteristic of the condition known as osteo1

•

u1Ci.i.cu.. i.a.

An important characteristic of vitamin D action is the lag time
after administration of vitamin D to a deficient animal before any
physiological response is noted.

The length of the lag time is from

4 to 24 hour.s depending on the dosage and the mode of administration.
The events that occur during this time are currently under intensive
investigation.

Important discoveriei;; in recent years that have partially

answered the question of what happens during this time period are the
isolation and characterization of biologically active metabolites of
vitamin D.

/

Metabolites of vita,min D first isolated were soon identified as
esters of vitamin D and long chain fatty acids (Fraser and Kodicek, 1965),
but these now appear to be of minor functional importance (DeLuca, 1967).

r':
--------------------------------------

'·

2

Another metabolite, more polar than vitamin
proved to be of major interest.

n3

(cholecalciferol)

This metabolite, when given to rachitic

animals, was more effective in the cure of rickets than the parent
vitamin (Blunt et al., 1968b).

It also stimulated intestinal calcium

transport and bone mineral mobilization more rapidly than did vitamin n
3
(Morii et al., 1967).

This active metabolite, isolated from plaiJma, by

silicic acid column chromatography, has been identified as 25-hydroxycholecalciferol (25-HCC) (Blunt et al., 1968a).

Also, 25-HCC has been

chemically synthesized and shown to be identical to the isolated material
(Blunt and DeLuca, 1969).

The corresponding metabolite from vitamin

n2

(ergocalciferol) has also been isolated and identified as 25-hydroxy-, ·
ergocalciferol (Suda et al., 1969).

In addition, dihydrotachysterol ,
3

a compound structurally related to vitamin D3 and with some 'b1o1og:i:cal
activity like vitamin D, has been shown to be converted to 25-hydroxydihydrotachysterol

3

in vivo

(Hallick and DeLuca, 1971).

Evidence that vitamin D must be hydroxylated at carbon 25 before it
is effective was obj:ained in isolated end-organ experiments.

Using an

intestinal perfusion system in which calcium transport can be studied,
Olson and DeLuca (1969) reported that direct infusion of as much as
250 µg of vitamin

n3

into the mesenteric artery of vitamin D deficient

animals had little or no effect on calcium transport.

On the other hand,

when 0.25 µg of 25-HCC/was infosed, calcium transport rose to normal
levels in about 1.5 hours.

Other evidence that 25-hydroxylation is

necessary for biological activity comes from studies of mineral
mobilization in fetal bone cultures.

Trununel et al., (1969} demonstrated

~

------------------------------------------------------------------------~
3

that as little as 0.9 International Units (I.U.) of 25-HCC per ml of
culture media induced release of previously incorporated calcium-45
from fetal rat bone, while as much as 400 I.U. per ml of vitamin n
was without effect.

3
These results provide strong evidence that 25-

hydroxylation of the vitamin D molecule is essential for its activity.
It is also evident from the above data that both intestine and bone
lack the ability to convert vitamin

n3

to 25-HCC.

The liver has been

indicated as the major, if not sole, site of the 25-hydroxylation of
vitamin

n3

by experiments dealing with the disappearance of radioactivity

from the plasma after

3

H-vitamin

n3

injection and the appearance.of

25-HCC in the plasma (Ponchon and DeLuca, 1969).

Total hepatectomy

resulted in the toal loss of ability for the formation of 25-HCC
(Ponchon et al., 1969}.

I!~t!-:

p::rfused liver and liver homogenates are

able to form 25-HCC in vitro (Horsting and DeLuca, 1969).
That 25-HCC is the major form of the vitamin circulating in the
blood has been shown
et al., 1969).

fo~

man as well as for experimental animals (Mawer

However, recently Cousins et al., (1970) have demonstrated

that 25-HCC is metabolized very rapidly to metabolites more polar than
25-HCC.

Previous work by Haussler et al., (1968) and Lawson et al., (1969b)

had already indicated the presence of a metabolite more polar than 25-HCC
in the nuclei of intes·tinal mucosal cells.

This metabolite was also

detected in liver, kidney, bone and blood (Lawson et al., 1969c).
/

In

the intestine, which contains the highest quantity of this metabolite,
the concentration is very low, and it has been found never to be above
1 ng/g tissue.

This metabolite, tentatively identified as 1,25-dihydroxy-

4
cholecalciferol, is the predominant form of the vitamin found in the
intestine after a physiological dose of vitamin D3 (Kodicek et al., 1970).
The biological activity of this metabolite has been reported to be at
least twice that of 25-HCC in stimulating intestinal calcium transport
(Kodicek et al., 1970; Myrtle and Norman,

1971)~

Myrtle and Norman (1971)

also report that this polar intestinal metabolite greatly shortens the
lag time for maximum calcium transport as compared to 25-HCC.

Omdahl

et al., (1971) also report that this metabolite is very active in
stimulating calcium absorption, demonstrating a shorter lag time than
25-HCC.

However, they found that this metabolite, while demonstrating

nearly equivalent bone mobilization activity, had less than one-half of
the antirachitic activity of 25-HCC.
1''raser and Kociicek (i..;/Oj

i1tsvc

iJt:a1LiGed th.:. site cf hiosynthesis

of 1,25-dihydroxycholecalciferol to be the kidney.

They found that the

intestine, liver, adrenals, parathyroid, thyroid, thymus, bone, erythrocytes and blood plasma all failed to convert 25-HCC to the "I-oxygenated
25-HCC".

DeLuca (1971) has reported that his laboratory has confirmed

the finding that this intestinally-active metabolite is generated

....

exclusively in kidney tissue.
Another metabolite of vitamin n3 has been isolated from plasma and
identified as 21,25-dihydroxycholecalciferol.
half as active as vit"lmin

n3

This metabolite is one-

in rats in the cure of rickets and in

intestinal calcium transport, but is more active in the mobilization
of bone,mineral (Suda et al., 1970).

The site of synthesis of this

metabolite which is preferentially active on bone bas not yet been found.

F:--------------~
~":

5

At present, it is not possible to state conclusiveiy what form of
vitamin D is the form active at the target tissues.

Hydro~ylation

at

carbon 25 has been shown to be necessary for activity, but whether 25-HCC
is active· in the target tissues or whether it must be further metabolized
is not yet clear.
metabolite"&· may,cbe

It is possible that both25-HCC and more polar
0

act:i~at

the target tis.sues•

The way in which vitamin D metabolites act at a cellular
regulate calcium transport has been suggested to involve
with the genetic material of the cell stimulating RNA and

leVftl,~o

interac~i~

subsequ,..~ly

protein synthesis. .Several lines of evidence support this mode\ ...ef,;;
vitamin D action.
Stohs et aL,

(1~67)

have, shown that administration of

vU;·f,.~;J~3

to rachitic rats stimu,l.ates two or threefold the incorporation
3H-orotic acid into the RNA of the intestinal mucosa.

This effett;i·t

occurred within 3 hours after vitamin D3 administration and
noted in the nuclear RNA.

Q~'"

·--

~·---···-··--

-·

-

was1•~ttcially

Izzo (1970) reported that vitamin D

a1•t

1;

increased the incorporation of 3H-orotic acid and 3H-uridine into.,\\Qne.
RNA., with some increase after 3 hours al:ld a maximal response·. 9 h•u:.;,a.

after administration of vitamin

n3 •

A careful study of the effe¢t

of vitamin D3 on nuclear metabolism in chick intestinal. nuclei

bJ

Lawson et al., (1969a) revealed that the proportions of RNA,.·DNA·and
protein of the isolated' nuclei were unaffected by the vi,tamin D status
of the animals.

However, the incorporation of

3

H-orotie acid into the

intestinal nuclear RNA was increased in vitamin D deficient chicks
only 10 minutes after.a 125 µg d9se of vitamin

n3 •

Also, they reported

~-------------.
6

that there ~as no st:i-)ation of DNA-dependent RNA polymerase activity
.. of the isolated nuclei from chicks treated with vitamin

n3 •

These

results suggest that since vitamin D does not cause an increase in RNA
polymerase activity, it must affect the other factor of the RNA
polymerase system, namely the chromatin.
The polar metabolite, which now appears to be 1,25-dihydroxycholecalciferol, has been shown to be selectively localized within

th;

nuclei

of the intestinal mucosa cells (Haussler and Norman, 1967; Haussf~r" ~t al.,
:l ;.,

.•• ;' i,

1968).

Lawson et al., (1969c) reported that isolated chromatin from
.

· r,t

f,,:,~'X( ~

i·ntestinal mucosa cells contained 50% of the radioactivity 16 hours after
injection of radioactively labeled vitamin n •
3

It has been sh~:'b;.
'

,',

".'~ -~

1-. _1

1.: .

Hallick and DeLuca (1969) more directly that vitamin D increases the
: I :; :' 'j

template activity of chromatin fr0m rat intestine.

In these experiments
.· '" ,

'f;"\';- <, ::.:

chromatin, isolated from vitamin D deficient rat intestine and frQIB
.··~'; .,_.

'.)·-; . : '•.

intestine from rats given vitamin D at various times prior to killing,
was incubated with highly purified !· coli RNA polymerase and nucleoside

~riphosphates
of

14

·containing 14 c-ATP in an appropriate medium.

Incorporation

c-ATP into the RNA during incubation was a measure of the template

activity of the chromatin.

In these experiments a very definite stimu•

lation in template activity following vitamin D treatment was demonstrated.
These results support the concept that vitamin D unmasks
/

s~cific

which are then available for transcription by RNA polymerase.

genes

The

messenger RNA thus produced could code for functional pto.teins involved
·in calcium metabolism.

~-·

_ _ _ _ __ ,
7

Two such proteins have been identified in the intestine which may
take part in the active transport of calcium.

Wasserman and his

colleagues have discovered, isolated and characterized a calciutn:""binding
protein from chick intestinal mucosa which appears following vitaminD
administration (Wasserman and Taylor, 1966; 1968; Wasserman et al., 1968).
This protein has a high. affinity for calcium and appears to be'correlated
with many aspects of intestinal calcium transport (Taylor and"Wasserman,
1969).

Another protein, a calcium-dependent adenosine triphoS'pltatase

has been demonstrated in the brush border isolated from the
rats and chicks given vitamin D
1970).

(Martin et al., 1969;

int~ine

of

Melancon and DeLuca,

Enzymatic activity is minimal or absent in animals deftc!"'-ent. in

vitamin D, and there is a correlation between the time of appeS:isnce of'
the calcium-dependent ATPase and ca:lcium transport.

The inter'l'i!ll4ffonship

between these proteins is not known, but it is possible that bothl&yitems
operate in calcium transport in the intestine or that the calcium•stimulated
ATPase may be associated in some way with the action of the cald.Q:n;.bi'.ndihg
protein.

v~J

··

No such proteins have been found in bone where vitamin D abfo· ·. '
plays a role in calcium metabolism.
have been unable to find a

In fact, Taylor and Wasse'rlllan: (1969)

calcium~binding

protein in bone.

They

report that if it is present it must be at a concentration of less than
10 µ,g/g of bone cells on a dry weight basis, which is abOU:t 200 times
less than that found in the intestinal mucosa of vitamin D treated
rachitic chicks.

Recently, Canas· et al.., (1969) have demonstrated that

one of the early effects of vitamin D on bone in rachitic chicks is the

r·-·---------..
8

stimulation of bone collagen synthesis, which would provide new matrix
for the deposition of mineral.

This stimulatory action of the vitamin

appeared to be somewhat specific for bone, because collagen synthesis in
the skin of the same animal was unaffected.
1.'he. effect of actinomycin D, an inhibitor of DNA-directed RNA
synthesis, on the actions of vitamin D is a subject of particular
interest in attempting to understand the mode of action of

D.

vit~min

Eisenstein and Passavoy (1964) first reported that the hypercalcemic
response to large doses of vitamin D was blocked by actinomycin D.
That actinomycin D blocks both the rise in serum calcium normally
induced·by vitamin D and the increased transport of calcium by the
intestine was shown by Zull et al., (1965) and Norman (1965).

Actinomycin

D given aftc:- vitatnin D adtuinistrat.i.0;;1 dfd nol block th* effect. of the

vitamin, suggesting tha.t it inhibits some very early event necessary for
-

the expression of the physiological action of vitamin D.

-·

--

_.. _

.

Stohs et al.,

(1967) fot,J.nd that actinomycin D completely blocked the vitamin D stimulated·
increase in RNA synthesis in intestinal mucosa.

In the intestinal perfusion

system describ.ed by Olson and DeLuca (1969), actinom}1cin D administered
to the animal prior to 25-HCC blocked the rise in calcium transport but.
actinomycin D given after 25-HCC had no effect (DeLuca, 1969).

Izzo,

(1970), however, found that the stimulatory action of vitamin D on RNA
synthesis in bone could_,not be completely blocked by pretreatment with
actinomycin D.
Actinomycin D is known to block DNA-dependent RNA synthesis by
binding to the do.uble .stranded DNA. · Actinomycin D interacts with a

~
--------------------------------------------------~
9
guanosine-cytosine nucleotide pair by intercalating its chromophore
between two adjacent base pairs in the DNA (Muller and Crothers, 1968).
However, little is known about the mechanism of binding of actinomycin D
to the cell nucleus in vivo.
-~

Ringertz and Bolund (1969) found that

preparations of deoxyribonucleoprotein bound only one molecule of
actinomycin per 35-140 nucleotides whereas DNA preparations bound'
1 actinomycin D per 14-20 nucleotides.

The binding of actinomycin D

to DNA in the chromatin of different eucarocytes showed properties
similar to the binding to DNA, but this binding was restricted by the
chromosemal proteins.
Low doses of actinomycin D have been shown to effectively suppress
the formation of nucleolar and cytoplasmic RNAs, while leaving the
synthesis o:t other nuclear RNAs relatively unaffected (Perry, 196.3) •
• '

;

~

;

<

Penman et al., (1968) have also studied this heterogeneous nucleoplasmic
RNA, whose synthesis is relatively unaffected by doses of

actin~cin

D

',','J:

which completely inhibit synthesis of ribosomal RNA.
unique base

c~position

This RNA has a

of 45 moles % guanine plus cytidine,

res~mbling
',

'·'

that of DNA, as compared with ribosomal RNA's 70 moles % guanine plus
cytidine.

This DNA-like RNA has been separated from other RNAs by

successive phenol extractions at increasing temperatures (Georgiev
et al., 1963).

Treatment at 25°c yields cytoplasmic RNA.wpich includes

transfer RNA and ribosDinal RNA.

0

.:•

. ,.

Treatment at 45 C yields nucleolar RNA

which is believed to be the newly formed ribosomal RNA.
6S

0

c

Extraction at

yields nucleoplasmic RNA, a heterogenous DNA-like RNA, which may be

a precursor to tnRNA.

This 65°c RNA fraction has been shown to have a

much greater template activity in a cell free system than the other
RNA fractions (Mach an:d Vassalli, 1965), but whether a small portion or
any of it is truly messenger RNA has yet to be shown.
An understanding of how actinomycin D blocks vitamin D action is
important in determining the actions of vitamin.D at the cellular level.
The failure of actinomycin D to completely inhibit the vitamin, n ..
stimulated increase in RNA synthesis in bone might reflect a relatively
larger increase in the synthesis of this heterogeneous nucleoplasmic
RNA in bone cells in response to vitamin D\treatment than in the intestine.
STATEMENI' OF .'!'..!!§. PROBLEM

The end effect of vitamin D ts the calcification of bone, ,bu.tr-lll:ttle
is known about the direct action of the vitamin on bone.

Most:' •udt.es

on vitamin D act:l.on have focused on its role in the intestinal:, absorption
of dietary cah:iw.

For

~ny

years it was widely accepted that, thi•

action was the sole basis for the antirachitic action of vitamin J).
The stimulation of bone mineral mobilization by large doses of vitamin D
was well known but was generally assumed to represent a toxic rather
t~an

a physiologic action of the vitamin.

Carlsson (1952) provicted

indirect evidence that low doses of vitamin D can enhance the

~nt

of calcium from skeletal tissue to blood by stimulating bone;res'.Orption.
This has been confirmed by the

findi~gs

of Blunt et al, (1968b.) who

/

showed that both vitamin n3 and 25-HC:C cause an increase in. the serum
calcium of vitamin D deficient rats on a calcium-free diet. ·There is
now general agreement that vitamin I> plays a role in the physiologic

rr-·

------------il

t·i
~? ..

r·
~..

regulation of bone resorption, but little is known about how the
vitamin acts on bone cells to cause this response.
Parathyroid hormone (PTH) is also an important factor in stimulating
bone resorption.

Steinberg and Nichols (1968) found a very 'early

stimulation by PTH of DNA-directed RNA synthesis in at least some bone
cells.

Owen and Bingham (1968) using autoradiography, found that PTH

stimulated RNA synthesis in osteoclasts and inhibited RNA synthe$:f.S in
osteoblasts.

Raisz (1970) has reported that after a few hours of.

exposure to 25-HCC or PTH, ·either singly or together, bone cultures
begin to show resorption and this process continues even when the' .,.
agents are removed.

Actinomycin D, when present during or immediately

after the treatment with 25-HCC or PTH, abolishes the bone resorption
response, but actinomycin D did not completely block the response when
given two hours after 25-HCC or PTH.

This indicates that an actinomycin

D sensitive step, which is presumably RNA synthesis, is involved in. the
induction of the resorptive response.
Izzo (1970) using an

in~

system found that vitaminD3 stimulated

the incorporation of RNA precursors into bone RNA.

Whether this increase

in RNA synthesis is related to bone resorption or in some way to the
calcification process is not known.

However, he found that pretreatment

with actinomycin D could not completely block the vitamin D stimulated
/

increase in RNA synthesis.

Since the synthesis of some nuclear RNAs

are known to be insensitive to inhibition by actinomycin D, it appeared

l.

possible that vitamin D was selectively stimulating the incorporation
3
3
.
----o..f-·H·--o_r_o_t_i_c_a_c_i_d_a_n_d_..,H_·_u_r_i_d_i_n_e_i_n_t_o_t_h_e_s_e..,·..n·u·c-le_a.._r_R_NA_._s_,_w_h_i_c_h_a_r_e___..,.
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postulated to be precursors of messenger RNA.

This messenger RNA could

conceivably code for some protein or proteins necessary for increased
calcium mobilization, or possibly for some protein such as collagen,
necessary for calcification of new bone.
The purpose of this research is to investigate the effect of
vitamin D on the ,synthesis of various types'of RNA in bone cells and to
determine the effect of .Pretreatment with actinomycin D.

An ,!!! ~itro

system will be used to permit isolation of RNA with a higher specific
activity than that obtained by Izzo (1970), but will still allow
suffieient time for vitamin
in the intact animal.

/

D3

to be metabolized to its active form
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CHAPTER II
MATERIALS AND METHODS

GENERAL EXPERIMENTAL DESIGN

Rachitic rats were obtained by maintaining 50-60 gram Holtzman rats
on a vitamin D deficient diet for 4 to 5 weeks.

Reduced growth and

increased serum alkaline phosphatase levels were used as paramet•rs to
determine that the rats were rachitic.
The rats were divided into two groups; in one group each rat
received an injection of 5,000 I.U. of vitamin

n3 ,

and each rat in the

other group received an injf;'ction of the vehicle only.

•, .:._ ·,

~- '

. ; '. 'r',

.In some experi.. ~~i ..i

ments, each rat received an injection of 100 µg of actinomcyin

·1:

-~. .

l) twO
....tt~'1 '. ·, .

Five·~s·.

hn,1rs pri O'!:' ti, trea t!t!ent wit!"! "!i tamin D or the vehicle.

~ r~i:.~:(t·f.

·

after the administration of the vitamin or vehicle the rats were

\th~t$~

sacrificed and the humeri, tibias and femurs removed.

Fragments of-

trabecular bone were dissected out, washed and incubated in Kreba"".Jinger
bicarbonate buffer containing l µCi/ml of 3H-uridine at 37°c in an·
•.

atmosphere of 5% C02 and 95% o2 for 4 hours.

'f

After incubation·ttMtllJone

fragments were washed repeatedly and the bone cells isolated.
In some experiments RNA was extracted from the bone celi~ ~-·, the
specific activity of the RNA was.determined to see if vit.aurl.~ 1lt 111''timulated
the incorporation of 3H;-uridine into RNA in this ~ vitl'.O

&y:a:*1&. The

RNA was extracted from the bone cell pellets with phertol•sdi.f:f'U*' dodecyl
sulfate (SDS).

The RNA was precipitated from solution With' sOdtum chloride

and ethanol at -20°c for 16 hours and collected by ceittrf'fugadori at

. 14

12,000 g for 20 minutes.

After treatment with DNase, residual protein was

removed by extraction with phenol-SDS, and precipitating and centrifuging
as above.

A Sephadex G-25 column was used to free the RNA from the phenol

and DNA nucleotides.

The RNA was then precipitated and centrifuged and

the final precipitate dissolved in a small volume of sodium acetate buffer
for spectrophototmetric rueasurement and for scintillation counting;

A

comparison of the specific activities of the treated and control samples
was made to determine whether or not vitamin D enhanced the incorporation
of 3 H-uridine into bone cell RNA.
In other experiments, the RNA was separated into two fractions by
sequential trea~ment with phenol and SDS at 45°c and 65aC.
of RNA was purified.-· and concentrated as above.

Each fraction

The specific activities

of the RNA fractions from treated and control animals were compared to
determine the effect of vitamin D and actinomycin D on the synthesis of
the various types of RNA.
ANIMAL MAINTENANCE
Male albino rats (Holtzman Company, Madison, Wisconsin) weighing
50 to 60 grams were maintained in a

~thout

sunlight on a vitamin D

deficient diet with a calcium/phosphorus ratio of 5.85 (Rachitogenic Test
Diet, U.S.P•, General Biochemicals, Chagrin Falls, Ohio).

Animals fed

a normal diet (Wayne Lab Bl ox, Allied Mills, Chicago, Illinois) served as
/

.controls.

A total of twenty control rats, used at various times over a

period of about one year, ranged in weight from 230 to 270 grams after
maintenance for four weeks on the normal diet•

One hundred thirty-four
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rats fed the vitamin D deficient diet, used as various times over the same
period of one year, ranged in weight from 70 to 90 grams.
DETERMINATION OF SERUM ALKALINE PHOSPHATASE
In addition to

red~ced

growth, serum alkaline phosphatase levels

were measured to confirm that the rats were rachitic.

Increased serum

alkaline phosphatase is one of the early signs of a rachitic state.
The method used for determination of serum alkaline phosphatase is
that of Bessey et al., (1946).

Alkaline phosphatase catalyzes the

hydrolysis of the substrate, p-nitrophenylphosphate into p-nitrophenol
and phosphate.

p-Ni trophe~ylphosphate absorbs in t.he ultraviolet region

but not in the visible range, whereas p-nitrophenol in alkaline medium
is yellow and has ;:i.n absorption maximum at 400 nm. .The phosphata9·e
activity is directly proportional to the amount of p-nitrophenol liberated
per unit time.
Preparation of Solutions
l• Alkaline,.buffer solution - 0.2

M Na2co3 -NaHC03 buffer, pH 9.4.

1.06 grams of Na 2co3 and 3.36 grams of NaHco3 are dissolved in
distilled water and the solution diluted to 250 ml.
2.

Substrate • p-nitrophenylphosphate
20 mg of p-nitrophenylphosphate (Sigma Chemical Company, St. Louis,
Missouri) is dissolved in 5 ml of distilled water and to this
/

solution is added 17 5 ml of the alkaline buffer solution, pH 9 .4 •
3.

.

Standard - p-nitrophenol, 5
69.6 mg of

p~nitrophenol

!!'t!
(Sigma Chemical Company) is dissolved
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in 0.02 !'! NaOH and diluted to 100.0 ml with 0.02 !'! NaOH.
Five microliters of various dilutions of the standard solution of
p-nitrophenol were added to 100 µl of substrate and 200 µl of 0.02 N NaOH.
After mixing, the optical density was measured at 410 nm in the Beckman/
Spinco 151 Spectro-Colorimeter.

This data which was used in the preparatior

of a standard curve is shown in Table I.

The linear relationship·•

between the optical density at 410 run and the concentration of

p-~itro-

phenol is shown in Figure 1.
Serum alkaline phosphatase measurements were carried out using serum
obtained from blood samples collected from the tail vein of the rats.
Five microliters of serum were added to 100 µl of substrate and
0

at 25 C for 30 minutes.

A blank was prepared by using 5 µl of

i~cubated
d~tii,lled

water and a standard was prepared with each determination using 5\µl
of 1.667 mM p-nitrophenol.
At the end of the incubation period, the reaction was terminated
by adding 200 ul of 0.02 !'! NaOH to each

tube~

The optical density was

measured at 410 nm in the Beckman/Spincol51 Spectro-Colorimeter.

A

correction for the yellowish color of serum was made by adding 5 µl of
serum to 300 µl of 0.02 !'! NaOH and substracting the optical density at
410 nm from that of the sample.
A unit of alkaline phosphatase activity is defined as the amount of
/

enzyme that will liberate 1 µm of p-nitrophenol in 1 hour: at pH 9 .4 and·
25°c.

For comparison of normal and vitamin D deficient values, the alkaline

phosphatase activity is expressed as units per milliliter of serum.
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TABLE I

STANDARD CURVE DATA FOR DETERMINATION OF SERUM ALKALINE PHOSPHATASE

µm p-Nitrophenol

Number of Samples .

x 10-3/ml

*

o.n.41o·nm*

± 0.005

2.2

4

4.5

4

9.1

4

0.084

18.2

4

0.161 + 0.009

27.3

4

0.238

± 0.016

36.4

4

0.314

+ 0.002

45.4

4

0.398 + 0.016

Mean + Standard Deviation

/

0.020

. 0.043 + 0.005

± 0~001

-
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Standard Curve for Determination
of Serum Alkaline Phosphatase
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TREATMENT WITH VITAMIN Q.

~

ACTINOMYCIN D

Five milligrams of crystalline vitamin D (Mann Laboratories,
3
.
New York, New York) were dissolved in 0.5ml of 95% ethanol and then
diluted to 10 ml with 1,2-propanediol.

Five milligrams of vitamin n3

are equivalent to 200,000 International Units: therefore, one milliliter
of··thts:,solution'··contrd.ned::.20;000 I. U. of vitamin

n3 •

E•elii"ra~o:·be··

treated with vitamin D received an intraperitoneal injection
of this solution containing 5,000 I. U. of vitamin

of

0.25 ml

n3 •

The control animals were injected with 0.25 ml of the vehicle.
This solution was prepared by mixing 0.5 ml of 95% ethanol

and

9.5 ml

of 1,2-propanediol.
A solution of act:inomycin D was prepared by dissolving •c.djlbmycin D
(Calbiochem, tos Angeles, California) to a concentration of 2off·i 14/ml in
0.9'% saline.

E.ach rat to be treated with actinomycin D recetvea an

intraperitoneal injection of 100 µg (0.5 ml) of thiS solution.
In each experiment, equal numbers of rachitic rats were injected
with vitamin D and With the vehicle.

The rats were injected at 20

minute intervals so that each animal could be sacrificed and the bone
samples prepared for incubation exactly 5 hours after injection.

In

some experiments actinomycin D was injected 2 hours prior to the
treatment with vitamin D or vehicle.
/

INCUBATION

Qf.

BONE FRAGMENTS

!il!!!

3

H-URIDINE

Five hours after treatment with vitamin
were sacrificed by decapitation.

n3

or vehicle the animals

The humeri, tibias and femurs· were
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quickly removed and placed in cold Krebs-Ringer bicarbonate buffer .
solution.

After all the bones from one rat were collected, each bone

was freed from extraneous tissue and split longitudinally.

The bone

marrow was washed out with pressure by using a syringe containing
Krebs-Ringer bicarbonate buffer solution and a 25 gauge needle·.
pieces· of trabecular bona were dissected out and washed again..

Small
The.,

cleaned bone fragments had a slight creamy color, but no visible
evidence of bone marrow contamination.
The bone fragments from each rat were placed in a small vial
containing 2.5 ml of the incubation medium and loosely covered with
aluminum foil.

The samples were incubated iri. a shaking water bath at

0

37 C in an atmosphere of 5% C02 and 95% 02 for four hours.

At the end

of the incubation period t'he samples were chilled in an ice bath and the
medium inunediately removed.

The bone fragments were then washed 4 times

with cold Krebs-Ringer bicarbonate buffer and 4 times with cold
phosphate-buffered saline (PBS) and kept.in cold PBS until all samples
in an experimental group were collected.
Preparation
1.

£f Solutions

Krebs-Ringer bicarbonate buffer with p mM glucose, pH 7.4
1000 ml of 0.90% NaCl

40 ml of 1.15% KCl
/

30 ml of 1.22% Cacl2

10 ml of 2.11%

I<HiP04

10 ml of 3.82% MgS04•7H20
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The above solutions are mixed and to this mixture is added
210 ml of 1.30% NaHC03 and 2.58 grams of glucose~

Five percent

COz is bubbled through the solution for 10 minutes to obtain a
. pH of 7 .4.

The buffer solution is stored in glass s·topi>ered

bottles in the cold.

2.

Incuuation;:me4ium. '·

3

.

H-uridine (Uridine-5-T) with a specific activity

:di· 24.9·

(Amersham/Searle, DesPlaines, Illinois) was obtained
concentration of l mCi/ml.

at

Ci/mM

a

A stock solution of 100 µ.Ci/ml

was prepared by diluting 1.0 ml of the 3H-uridirie to 10.0 ml
with distilled water..

Incubation media was made by diluting

3
1.0 ml of the stock solution of . H-uridine to 100.0

ml of

Krebs-Ringer bicarbonate buffer, giving a concentration of

1 µCi/ml of
3.

3

H-uridine.

Phosphate buffered saline (PBS)
A solution of 2. 90 g/l of Na2HP04 •7H20 in 0 .15 M NaCl and a

solution of

O. 768 g/l of NaH2 Po4 ·u2 o in 0.15 M NaCl were mixed

in proportions to give a pH of 7.4.

-

-

_

ISOLATION
CELLS
....._......_.
______ OF BONE ...._
..........

The method employed for the isolation of bone cells is based on the
procedure described by Nichols et al., (1965).

The bone fragments from

/

6 to 12 animals on a like treatment were pooled and transferred to a
cold mortar~

The bone fragments were ground by hand for 3 minutes with

about 10 ml of a soluti.on of PBS containing 0.0673 grams of calcium chloride

. {CaCl2 ·2H20) pfa'r: ,l.00 .ml o,LPBS.

The liquid

wa~,.

then trana £erred to conical .
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centrifuge tubes.

The grinding of the residue was repeated 2 more times,

adding the liquid to the previously collected solution.

This solution

was then allowed to stand in the conical tubes in the cold for 20 minutes.
The calcified matrix material settles to the bottom of the tube and the
cells remain in solution.

The supernatant was carefully removed, placed
:

"

.,

-.~,,

.

:.

..

-

in other, tubes, and.bone cells were·collected in a pellet·bf·~~i'i~4agQni•"i ·
at 750 g for 10 minutes (Sorvall, Refrigerated Model RCB-2, with SS-1
Rotor).

0

The bone cell pellets were kept frozen at -20 C until extraction

of RNA.

•

To confirm that we were isolating bone cells and not bone marrow
cells, both were examined by light microscopy.

Bone marrow was collected

from bones which had been split longitudinally by scooping out the bone
marrow and collecting

it

in a tube containing cold PBS.

collected by centrifugation at 750 g for 10 minutes.

The cells were

Both bone cell and

bone marrow cell pellets were fixed in osmic acid ~nd embedded in' Epon.
One micron sections were stained with toluidine blue and examined by
light

microsco~y.

EXT,MCTION OF RNA
The method used for extraction of RNA was the widely used phenol
extraction method described by Kirby (1956) which depends 011 the
part:ition o.f RNA between aqueous buffer and 88% phenol.

Steinberg

/

and Nichols (1967) used this method to isolate RNA from normal bone
cells.

The method outlined below is the same as that used by Steinberg

and Nichols· except for the use of .a Sephadex G•25 column to separate

RNA from phenol.
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The pellet of bone cells was homogenized in 9 ml of a sucrose
medium composed of 0.25 M sucrose and 1 mM MgC1 2 in 10
buffer, pH 7.4, using a ground glass homogenizer.

~

Tris-HCl

The homogenate

was made 0.5% with respect to SDS by adding 1 ml of a 5% solution· of
SDS.

After stirring for 10 minutes at room temperature, an equal volume
0

(10 ml) of phenol was added and the sample stirred at 4 C for 30 minutes.
Centrifugation at 12,000 g for 10 minutes was used to break the emulsion.
The upper aqueous

p~ase

and the material at the interface were removed
0

and reextracted with 5 ml of phenol for 10 minutes at 4 C and centrifuged.
The phenol layer obtained in the first centrifugation was reextracted
with 10 ml of the sucrose medium for 10 minutes at

4°c and centrifuged.

The aqueous phases from each of these two latter centrifugations were
carefully removed and combined.
The RNA was precipitated from solution by adding 0.1 volume of
·o

2 !! NaCl and 2 volumes of 95% ethanol and storing overnight at -20 C
in a freezer.
20 minutes.
0.02

The RNA was collected by centrifugation at 15, 000 g for.

Mgso

The precipitate was resuspended in 8 ml of 0.02 !

MTris-HCl

buffer, pH 7.4.

4

in

This solution of RNA was treated with

deoxyribonuclease (Worthington Biochemical Corp., Freehold, New J•rsey),
at a concentration of 10 µg/ml for 20 minutes at room temperature,tith
stirring.

The residual protein was removed by extracting again ,n.th 0.5%

. SDS and 0.5 volume of phenol for 15 minutes at

4°c. After centdfugation

/

to break the emulsion the aqueous phase was removed and the RNA

was

precipitated from solution with sodium chloride and ethanol as before.

.

.

After 90 minutes or longer, the precipitate was collected by centrifugation.'
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This precipitate was dissolved in l to 2 ml of distilled water
and was passed through a Sephadex G-25 column to remove the DNA nucleotides and phenol.

The eluent from the column was monitored in

a

Beckman DB spectrophotometer, using a 5

nun

flow cell, by observing the

increase in optical density at 258 nm.

The RNA collected from the

column was again precipitated with sodium chloride and ethanol and the·
final precipitate dissolved in a small volume of 0.25 M sodium acetate
buffer, pH 5.3.
The amount of RNA present was determined by using a standard
yeast RNA sample (Sigma Chemical Company) and the Beck.man DB spectrophotometer at a wavelength of 258 nm.
PHENOL FRACTIONATION OF RNA
RNA was extracted in the same way as described before, except
that after stirring the bone cell homogenate-phenol-SDS mixture for .
0

30 minutes at 4 C, this mixture was heated and stirred for 15 minutes
at 45°c •. After centrifugation to break the emulsion the upper phase
was removed without disturbing the interface and the lower phase and
interface were reextracted with sucrose media and SDS for 15 minutes
at room temperatuTe.

After centrifugation the upper phase was carefully

removed and combined with the previous aqueous phase.

The combined

aqueous phases were reextracted with 5 ml of phenol for 15 minutes at
room temperature.

/

After centrifugation, the upper phase was removed

and the RNA precipitated from solution as described in the.. previous
section.

r..----------------------------------------.
~
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Sixty-five degree RNA was extracted by adding fresh phenol to the
interface material and homogenizing with SDS and sucrose media.

After

stirring for 10 minutes at room temperature, the sample was heated and
0

stirred at 65 C for 15 minutes.

It was then centrifuged, reextracted

and precipitated in the same manner as the 45°c RNA.
Each of these samples, 45°c RNA and 65°c RNA, were then treated·
with DNase, extracted again with phenol, separated on a Sephadex G-25
column and the amount of RNA present determined as described in the
previous section.
LIQUID SCINTILLATION COUNTING
A 0.2 or 0.5 ml aliquot of the sample of RNA was placed in· a.
liquid scintillation counting vial and to this was added 15 ml of the
toluene counting solution.

The toluene counting solution was prepared

by dissolving 5 grams of PPO (2,5-diphenyloxazole) in one liter of toluene.
To every 100 ml of this solution was added 20 ml of Beckman solubilizing
reagent Bio-Solv BBS-3.

The samples were counted in the LS-250

Liquid Scintiliation Spectrometer using the automatic quench correction.
A quench curve was prepared by.adding various amounts of RNA isolated
from bone cells in 0.25 M sodium acetate buffer, pH 5~3 to 15 ml of
the toluene counting solution containing 0.1 µ.Ci of 3H-:uridine.

These

samples were counted with the LS-250 Liquid Scintillation Spectrometer
/

(Beckman Instruments) using the automatic quench correction.

The per cent

efficiency was plotted against the external standard ratio (Figure 2).
The specific activity of the RNA was expressed as disintegrations
. per minute per milligi::am of RNA (dpm/mg RNA).
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CHAPTER III
EXPERIMENfAL RESULTS
SERUM ALKALINE PHOSPHATASE ACTIVITY IN NORMAL AND RACHITIC

~

Serum al.kaline phosphatase measurements were made on two rats fed
a normal diet and two or three rats fed a vitamin D deficient for 4 weeks
selected at random from each group of animals to be used for a given
experiment.

As shown in Table II, the serum alkaline phosphatase levels

of the vitamin D deficient rats were significantly higher than those of
rats fed a normal diet.

These results, in accord with the much lowe-.:-

body weight, show that the rats fed a vitamin D deficient diet are·
indeed rachitic.

Additionally, this conclusion was confirmed by the

appearance of the bones when ·the rats were sacrificed.

-

BONE CELL PREPARATI.ONS

Since the spaces in trabecular bone are filled with bone marrow
cells, it was necessary to determine that the cells released by grinding
trabecular bone fragments were bone cells and not bone marrow cells.
Bone cell pellets were a creamy white color.

The absence of a grossly

red color as one sees with bone marrow cells was one of the criteria used
to determine that bone cells and not bone marrow cells were being isolated.
Histological examination of bone cell and bone marrow cell preparations
showed that although

t~e

bone cell pellets contained a heterogetious

mixture of cells (Figure 3), there were very few cells typical of bone
marrow such as red blood cells, megakaryocytes and myeloid cells (Figure 4).
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TABLE II
SERUM ALKALINE PHOSPHATASE ACTIVITY OF NORMAL AND RACHITIC RATS
(units/ml serum)
Normal
3.09

6~44

1.75

5.17

1.96

4 •. 87

2 .49

5.78

2.74

5.83

2.65

4.30

2.44

4.66

2 .46

4.16

2.73

·. 5.19

2.49

*

'

..

;;<

5.53

2.84

5.17

. 2.26

4.54

.2 .48

. 5.42

2.56

4~64

2.83

3.95

3.05

6.24:

2.56 + 0.32

4.75
7.30
/

4.93

*

Mean

± Standard

neviation.

*

5.20

±

0.84
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/

FIGURE 3.

Isol a ted Bone Cells

(x 600)

30

FIGURE 4.

Bone Mar:row Cells (x 600).
(a) megakaryocyte, (b) myeloid
cell,
(c) red blood cell.
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It appears that this procedure results in the isolated of bone cells
relatively uncontaminated with bone marrow cells.
~ ~ BONE CELLS

A typical separation of RNA from phenol on a Sephadex G-25 column
is shown in Figure 5.

To establish that.any DNA digested by DNase·

..

treatment would be separated on this column, an excess of DNA {Worthington
Biochemical Corp.) was digested with DNase and passed through the coluinn
(Figure 6).

No such peaks were observed between RNA and phenol in any

of the experiments, indicating that little or no DNA was extracted.
The spectrum of RNA isolated from bone cells of eleven rachitie ·
\

rats is shown in Figure 7 and for comparison a spectrum of purified

in each sample in the various experiments ranged from 5 to 25 µg.

The

optical density at 258 nm was used to calculate the amount of RNA· present.
3 .

-

THE INCORPORATION OF

----

EFFECT OF VITAMIN D ON

-

'

-H-URIDINE

---INTO BONE CELL

RNA IN VITRO
---Two experiments were carried out in order to determine the ef·fect
of vitamin D3 on the incorporation of
using an in vitro system.

3

H-u~idine into bone c~:~l

Bi*-

In each experiment 8 rachitic rats w.e:re
'

injected intraperitoneally with 5,000 I.U. of vitamin D3 and 8 rachitic
rats were injected with the vehicle only.

Rats were injected at 20 minute

intervals so that.each animal could be sacrificed and the tibias, femurs
and humeri removed and cleaned exactly 5 hours after treatment.

Bone
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fragments were incubated for 4 hours with 3n-uridine and then washed
and chilled in an ice-bath to stop the incorporation of the isotope.
A total of 9 hours from the time of treatment with vitamin D or vehicle
to the end of the exposure to 3n-uridine was chosen because Izzo (1970)
found that 9 hours was. the time of maximal incorporation of precursors
into RNA in bone using an in

~

system.

The bone fragments from the 8 rats in each experimental group
were pooled and bone cells isolated.
as described in Chapter II.

RNA was extracted and measured

Aliquots were then used for scintillation

counting and the specific activity expressed as disintegrations per
minute per milligram of RNA.
In hoth evperim~nts, t"1e sped f:I r ~rt:iir:f ty of the RNA ft'o'!TI

th.,, ·

vitamin. D treated animals was greater than that of the controls (Table III).
The ratios of the specific activity of the RNA from vitamin D treated
rats and the specific activity of the RNA from rats treated with the
v~hicle

only (T/C ratio) were comparable to the results reported by
.,. '' ''' ·?.;

Izzo (1970) which were 1.3_6, 1.06, 1.48, 1.74 and 1.42 giving an average
of 1.4.

The specific activity of the RNA in these. experiments was about

forty times higher than those of the in .Y!!.£ experiments by Izzo (1970).
It can be concluded from these results that, in agreement with
the experiments of Izzo (1970), vitamin D does enhance the incorporation
/

of

3

H-uridine into RNA into bone in this in vitro system.
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TABLE III

EFFECT OF

VITA.MI~ D ON THE INCORPORATION OF 3H-URIDINE INTO BONE CELL
RNA IN VITROa

Experiment

Specific Activity of RNA
(dpm/mg RNA)
control

1

Vitamin D
Control

2

133,248
88,507

Vitamin D
8

71, 708

117 ,962

Treatedb
Control

± 1076c
±

1.86
1999

± 1328
±

1.33

1769

Rachitic rats were sacrificed 5 hours after injection with 5,000 I.U. of
vitamin
3

n3

H-uridine.

or vehicle.

Bone fragments were incubated for 4 hours with

RNA was extracted from bone cells isolated from these

bone fragments.
b

Ratio of the specific activity of RNA from vitamin D treated rats and
the specific activity of RNA from rats treated with the vehicle only.

cSpec i fie activity

±

1. 5% counting error.

/
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Q. ON THE VITAMIN Q.. STIMULATED INCORPORATION .QK

--

-

3H-URIDINE --........
INTO.BONE
CELL ---:--RNA -IN --VITRO
_.,....
The next experiment was designed to determine the effect of
actinomycin D on the increased incorporation of 3H-uridine into bone
cell RNA following vitamin D treatment in this in vitro system.

The

procedure was the same as outlined in the previous experiment.

Each

rat received two intraperitoneal injections of 50 µg each of actinomycin D,
on.e 6 hours before and one 2 hours before treatment with vitamin D or
vehicle.

Each of the two experimental groups consisted of eight animals.

The results shown in Table IV indicate that actinomycin D was
effective in decreasing the incorporation of 3H•uridine into RNA in both
the vitamin D treated and control animals as compared with those animals
not treated with actinomycin D (Table III).

However, the specific activity·

of the bone cell RNA from vitamin D treated animals was still greater
than that of the controls.
EFFECT OF VITAMIN Q. ON THE INCORPORATION OF 3!!-URIDINE INTO BONE CELL

-

RNAS EXTRACTED AT 45°C AND 65°C

------.-

The synthesis of some nuclear RNAs, which are thought to be precursors
to messenger RNA, have been shown to be unaffected by actinomycin l>
pretreatment.

These RNAs can be isolated by sequential fractionation

with phenol-SDS.
RNA.

Treat~ent at 45°c should yield cytoplasmic and nu~leolar

Following treatment at 45°c these nuclear RNAs, insensitive to
0

actinomycin D, can be obtained by extraction at 65 c.
The next two experiments were designed to determine the effect of
vitamin D on the incorporation of 3H-uridine into these two fractions of
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TABLE IV
EFFECT OF ACTINOMYCIN D ON THE VITAMIN D STIMULATED INCORPORATION OF
3
8
H.. URIDINE INTO BONE CELL RNA IN VITR0

Specific Activity of RNA
(dp&Qmg. ,J.lliA)
Control

13,557

± 407c

Vitamin D

22 ,816

± 684

Treatedb
· Contr.ol

1.68

aRachitic rats were given two intraperitoneal injections of 50 µg of
actinomycin D 6 hours and 2 hours before an injection of 5,000 I.U.
of vitamin D3 or vehicle.
with

3

H-uridine.

Bone fragments were incubated for 4 hours

RNA was extracted from bone cells isolated from

these bone fragments.
bRatio of the specific activity of RNA from vitamin D treated rats and
the specific activity of RNA from rats treated with the vehicle only.
cSpecifiC activity± 3.0% counting error.

/
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RNA.

Two experimental groups, each consisting of eight animals, were

used.

The experiments were carried out as previously described, but

the. RNA was separated into two fractions as described in the chapter on
Materials and Methods.
The results presented in Table V show that vitamin D stimulated
the incorporation of. 3H-uri.dine into both 45°c a~ 65°c RNA.

In both

experiments, the treated/control ratio of specific activities was
0

0

greater for the 65 C than for the 45 C RNA..
EFFECT OF ACTINOMYCIN Q.

___

QN THE VITAMIN Q. STIMULATED INCORPORATION OF

3H-URIDINE INTO BONE CELL RNAS EXTRACTED AT 45°C AND 65°c
....__..__
.

-----

The next experiment tested the effect of actinomycin D on the
vitamin D stimulated incorporation of 3H-uridine into the two RNA
fractions.

The experiment was done as previously described except

that 12 rats were used in each experimental groups and each rat received
an intraperitonealinjection of 100 µg of actinomycin D two hours before
1

treatment with vitamin D or vehicle.
The results given in Table VI show that actinomycin D did not
inhibit the vitamin D stimulated incorporation of
45°c or 65°c RNA.

3

H-uridine into either

In fact, the treated/control ratio of specific activities

of the 45°C RNA appears to be increased by actinomycin D pretreatment.
3
Vitamin D increased the incorporation of H-uridine into both
/

fractions of bone cell RNA and this response was not inhibited by
actinomycin D. ·
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TABLE V
EFFECT OF VITAMIN DON THE INCORPORATION OF

3
H-URIDINE INTO BONE CELL

RNAS EXTRACTED AT 45°c AND 65°c

8
\

Experiment

1

Temperature of
Extraction of RNA
45°C

0

65 c

Specific Activity of RNA
(dpm/mg RNA)

Control

24,078 ±

482

Vitamin D

29,334

±

587

Control

34,473 ±

689

Vitamin D

49,902 ±

998

Control

56, 954 ± 1139

Vitamin D

76,122 ± 1534

Treated
Control

c
1.22

1.45

2

45°c

1.35
v )

65°c

Control

17 ,447 ±

Vitamin D

28,276 + 566
'

8

'

349

t';i,

'1.62

-

Rachitic rats were sacrificed 5 hours after injection with,~im f.~u. of
vitamin o3 or vehicle. Bone fragments were incubated for 4 hours ~th
' :,' ~'.·~ .·~;. b. !'· '4,,f·l{;'. ~~·.
3
.
H-uridine. After isolation of bone cells, RNA was fracti~ted into
0

RNAs extractable at 45 C and 65
b

0

c.

Ratio of the specific activity of RNA from vitamin D treated rats and
the specific activity of RNA from rats treated with the
/

c

Specific activity± 2.0% counting error.

veh~cle

qnly.

b
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TABLE VI

EFFECT OF ACTINOMYCIN D ON THE VITAMIN D STIMULATED INCORPORATION OF
3

H-URIDINE INrO BONE CELL RNAS EXTRACTED AT 45°c AND 65°c

.

Specific Activity of RNA
(dpm/mg RNA)

Temperature of
Extraction of RNA.

± 408

Control

20,379

Vitamin D

37,663±753

Control

33,333

±

Vitamin D

49,583

± 992

8

. b

Treated
Control

c

1.85

667
1.49

8Rachitic rats were given 100 µg of actinomycin D intraperitoneally
2 hours before 5,000 I.U. of vitamin D3 or vehicle. Bone fragments
3
were incubated for 4 hours with H-uridine. After isolation of bone
0

0

cells, RNA was fractionated into RNAs extractable at 45 C and 65 c.
bRatio of the specific activity of RNA from vitamin D treated rats
and the specific activity of RNA from rats treated with the vehicle
only.
cspecific activity± 2.0 % counting error.
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CHAPTER IV
DISCUSSION AND CONCLUSIONS
Vi~~n

D has been·reported to cause many metabolic changes

including alteTations in bone citrate content (Carlsson and Hollunger,
1954), phospholipid metabolism (Thompson and .neLuca, 1964; Neville.:,:....
Holdsworth,. 1968), ca2+ release by mitochondria (Engstrom and DeLuc•,
1964} and ·adenyl cyclase activity (Neville and Holdsworth, 1969),. but
the relation of these changes to the physiologic actions of vitamin,l),&Jie
not known.

The question that arises here is whether the increased

incorporation of nucleic acid precursors into RNA observed.in bone under
the stimulus of

vit~n

D is directly involved in the mod• of action of

The effect of vitamin D on RNA synthesis in otheT tis,ues is of
particular interest in respect to this work.

In the .intestine, Stohs

et al., (1967), found that after the administration to rats of a 2,000
I.U. dose of vitamin

n3 ,

maximal inc.oTporation of

3
H•orotic acid int'>

nuclear RNA occurred at j hours with a T/C ratio of 2.81; however, this
increase could be completely blocked by actinomycin D given 2 hours
before treatment with vitamin D.
chicks that 125 µ.g of vitamin

n3

Lawson et al., (1969a) found in
increased the incorporation of

3

H-orotic

acid into nuclear RNA; jn three experiments they found T/C ratios of 1.83,
1.13 and 5.02, one hour after intracardial injection.
Stohs et al., (1967) also studied the effect of vitamin D on
3u-o~otic acid i~orporation into nuclear RNA of _rat liver and kidney,

.
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tissues that are not known to be affected by vitamin D.
T/C ratios of 1.30 for liver and L53 for kidney.

They found

These values are

in the same range as those found for bone.
A possible explanation for the increased RNA synthesis in kidney
can be found on the basis of a recent report by Tanaka and DeLuca (1971).
They found' that actinomycin D administered prior to radioactive 25-HCC
blocked the metabolism of 25-HCC to the polar metabolite(s) that accumulate
in the intestinal tissue.

The site of biosynthesis for at least one of

these metabolites is the kidney (Fraser and Kodicek, 1970).

Actinomycin D,

however, did not prevent the 25-hydroxylation of vitamin D3 in the liver.
There is considerable evidence that vitamin D or its metabolites
can interact with DNA to stimulate RNA synthesis in the intestine, and
possibly in the kidney.

'there is· also some evidence from organ cultures·

that this interaction precedes bone resorption.
experiments indi<:ate that vitamin

n3

The results of our

does increase the rate of synthesis

of both ribosomal and nucleoplaemic RNA in bone cells.

The increased

synthesis of RNA found in our system may be related to resorption, but
since vitamin D is needed for normal calcification in addition to the
resorption process even in the presence of an adequate dietary supply
of calcium and phosphorus (DeLuca, 1967), the increase co1,1ld be related
to the calcification process.
The synthesis of the RNA extracted at

4°c

in these experiments,

which is most likely cytoplasmic RNA, was found to be larg.ely inhibited
by actinomycin D; however, the specific activity of the RNA from vitamin D
treated animah was. still larger than that of the controls. The two fraction
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of RNA (45°C and 65°c) obtained in these experiments showed increased
incorporation of 3H-uridine into RNA, and this increased incorporation
was not blocked by actinomycin D pretreatment.

This indicates that

vitamin.D stimulated the synthesis of all nuclear RNAs in bone cells
and not spe,cifically the DNA-like nucleoplasmic RNA resistant to actinomyciti D inhi.bition.

In fact, the synthesis of RNA which can be extracted

at 45°c, which others have found to be completely blocked by actinomycin D
•

'•j

•

(Ceorgiev• 1967), appears to be increased in animals treated with actinomycin D and vitamin D (T/C ratio= 1.85) over those animals not treated
with

ac~inomycin

D (T/C ratio= 1.22 and 1.35).

Whether these numbers

are significant is not knowri, but it is of interest to note that Izzo
(1970). found that in each of three experiments where .RNA

~as

extracted

at 65°c only, the Tfe ratio was higher in the animals ttea~ed with
actinomycin D than those treated with only the vitamin (T/c· ratio 1.53
as compared to 1.31; 1.54 to 140; and 1.49 to 1.14).
Why actinomycin D does .not inhibit the vitamin D stimulated increase
i.n 45° RNA synthesis is puzzling.
vitamin

n3

of 5,000 I.U. which is 500 times that considered physiological

(10 I.U.) may be overcoming

Wass~~an

One possibility is that the dose of

th~

effect of actinomycin D.

Corradino and

(1968): reported that While actinomycin D inhibits the formation

i
of vitamin D induced calcium-binding protein in the intestinal mucosa,

this inhibition can be /overcome by large doses of vitamin D.

Complete

..

inhibition of formation of calcium-binding protein was achieved when
the vitamin

n3

dose was 100 I.U., but with 250 and 500 I.U. of vitamin D3

progressively less inhibition was seen.

Stohs et .al., (1967), however,

45

used doses of 2,000 I.U. of vitamin D3 and found that the increase in RNA
synthesis caused by vitamin D3 in the intestine could be completely
inhib;i.ted by actinomycin D.
· In summary, it was found that vitamin D increased the incorporation
3

of H-uridine into all types of bone cell RNA.

The vitamin I> stimulated

with actinomycin D, but vitamin D stimulated synthesis of nucleolar and
nucleoplasmic RNA remained unaffected following actinomycin D treatment.
It appears· from these experiments that one effect of vitamin Dis the
.stimulation of RNA synthesis in bone cells, but the importance of this
increased RNA synthesis in the mode of action of the vitamin is not yet
clear.

/
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